-
The resynchronization reverses remodeling in Systolic Left Ventricular Dysfunction (REVERSE) trial tested the hypothesis that cardiac resynchronization therapy (CRT) would benefits patients with New York Heart Association (NYHA) functional class I and II heart failure and a prolonged QRS duration.
-
The catheter ablation versus antiarrhythmic Drugs for Atrial Fibrillation (A4) study compared radio-frequency catheter ablation to antiarrhythmic therapy in selected patients with paroxysmal atrial fibrillation (PAF).
-
-
Drug combinations for hypertension; tenecteplase for out-of-hospital cardiac arrest; CAM most commonly used for back, neck, and arthritis pain; FDA Actions.
-
Dual antiplatelet therapy (DAPT) following coronary stenting is essential for the prevention of stent thrombosis, which can occur due to a response to the vascular scaffold, as well as to the local inflammation that occurs after angioplasty. DAPT after drug-eluting stent (DES) implantation is currently recommended for at least 12 months in the United States and for 6 months in Europe.
-
Symptomatic left ventricular outflow tract (LVOT) obstruction is common in patients with hypertrophic obstructive cardiomyopathy (HOCM), and medical therapy does not always relieve the symptoms. In such cases, septal reduction therapies are indicated, and both alcohol septal ablation (ASA) and surgical myectomy have been proven to reduce symptoms effectively.
-
Although carotid artery stenting (CAS) is a less invasive means of carotid revascularization, multiple trials have demonstrated an increased risk of post-procedural stroke in patients with symptomatic carotid stenosis, as compared to carotid endarterectomy (CEA).
-
Transesophageal echocardiography (TEE) is commonly performed prior to atrial fibrillation (AF) ablation to exclude left atrial appendage thrombus.
-
Low-flow, low-gradient aortic stenosis (AS) is usually associated with reduced left ventricular (LV) performance. When LV systolic function is normal, it has been labelled paradoxical.
-
Perioperative risk of major non-cardiac surgery in patients with severe aortic stenosis: a reappraisal in contemporary practice.
